GrayBug announces funding round, appointment of president, CEO

GrayBug announced the close of a Series A funding round of $1.5 million, according to a press release.The funding will be used for the development of drug delivery therapies, working toward human clinical trials in wet age-related macular degeneration and glaucoma. Maryland Venture Fund led the financing round, along with the Abell Foundation and Brown Advisory.

Full Story →